These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23092517)

  • 41. Targeted therapy for hematologic malignancies.
    Kuriakose P
    Cancer Control; 2005 Apr; 12(2):82-90. PubMed ID: 15855891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Antiblastic chemotherapy and immunity in childhood].
    Nigro N; Madon E; Baroncelli PG; Martini Mauri M
    Minerva Pediatr; 1970 May; 22(20):1035-44. PubMed ID: 4102348
    [No Abstract]   [Full Text] [Related]  

  • 43. How I treat lymphoma in pregnancy.
    Dunleavy K; McLintock C
    Blood; 2020 Nov; 136(19):2118-2124. PubMed ID: 32797210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Acute leukemia and pregnancy--some postulates].
    Savchenko VG
    Ter Arkh; 2009; 81(7):5-7. PubMed ID: 19708566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
    Rossi G; Pelizzari A; Motta M; Puoti M
    Br J Haematol; 2001 Oct; 115(1):58-62. PubMed ID: 11722410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fourth biannual report of the Cochrane Haematological Malignancies Group.
    Kober T; Hülsewede H; Bohlius J; Engert A
    J Natl Cancer Inst; 2006 Apr; 98(8):E1. PubMed ID: 16622111
    [No Abstract]   [Full Text] [Related]  

  • 47. Current problems in the use of the oncolytic drugs.
    Armstrong JG
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):270-7. PubMed ID: 4298202
    [No Abstract]   [Full Text] [Related]  

  • 48. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)].
    Arroyo de la Fuente F; Lasheras Garde J; Triginer Boixeda J
    Sangre (Barc); 1966; 11(3):265-70. PubMed ID: 6012465
    [No Abstract]   [Full Text] [Related]  

  • 49. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
    Danieli G
    G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460
    [No Abstract]   [Full Text] [Related]  

  • 50. Update on the proteasome inhibitor bortezomib in hematologic malignancies.
    Goy A; Gilles F
    Clin Lymphoma; 2004 Mar; 4(4):230-7. PubMed ID: 15072615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytotoxic therapy and pregnancy.
    Ebert U; Löffler H; Kirch W
    Pharmacol Ther; 1997; 74(2):207-20. PubMed ID: 9336023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obstetrical, fetal and postnatal effects of gestational antiblastic chemotherapy: how to counsel cancer patients.
    Del Pup L; Peccatori FA; Azim HA; Michieli M; Moioli M; Giorda G; Tirelli U; Berretta M
    Int J Immunopathol Pharmacol; 2012; 25(2 Suppl):33S-46S. PubMed ID: 23092518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel agents for the treatment of lymphomas during pregnancy: A comprehensive literature review.
    Luttwak E; Gurevich-Shapiro A; Azem F; Lishner M; Klieger C; Herishanu Y; Perry C; Avivi I
    Blood Rev; 2021 Sep; 49():100831. PubMed ID: 33931297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial.
    Yang B; Lu XC; Yu RL; Chi XH; Liu Y; Wang Y; Dai HR; Zhu HL; Cai LL; Han WD
    Hematol Oncol; 2012 Sep; 30(3):115-22. PubMed ID: 22972689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biannual report of the Cochrane Haematological Malignancies Group.
    Trelle S; Higgins G; Kober T; Engert A
    J Natl Cancer Inst; 2004 Aug; 96(15):E2. PubMed ID: 15292394
    [No Abstract]   [Full Text] [Related]  

  • 56. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
    Zuckerman E; Zuckerman T; Douer D; Qian D; Levine AM
    Cancer; 1998 Sep; 83(6):1224-30. PubMed ID: 9740089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Optimising therapy in patients with haematological malignancies].
    Dumontet C
    Bull Cancer; 2008 Oct; 95(10):959-62. PubMed ID: 19004726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
    Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
    Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Second malignancies and chemotherapeutic agents.
    Kyle RA
    Prog Clin Biol Res; 1983; 132E():45-54. PubMed ID: 6417671
    [No Abstract]   [Full Text] [Related]  

  • 60. Fifth biannual report of the Cochrane Haematologic Malignancies Group--Focus on multiple myeloma.
    Naumann F; Weingart O; Kruse E; Schulz H; Bohlius J; Hülsewede H; Engert A;
    J Natl Cancer Inst; 2006 Aug; 98(16):E2. PubMed ID: 16912255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.